Royalty Pharma plc Class A Ordinary Shares vs Teucrium Soybean Fund — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B), while Teucrium Soybean Fund trades at $27.42 (market cap $43.52M). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 580.7× Teucrium Soybean Fund's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Teucrium Soybean Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Teucrium Soybean Fund for 23 Days on average.
| RPRX | SOYB | |
|---|---|---|
Market Cap | $25.27B | $43.52M |
Volume | 3,671,183 | 32,585 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $63.96 | $28.14 |
52-Week Low | $35.44 | $21.55 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $32.50B | — |
Dividend Yield | 1.66% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →